Breast Cancer 3Day
Encyclopedia
The Susan G. Komen 3-Day for the Cure, frequently referred to as the 3-Day, is a 60-mile walk to raise funds and awareness to fight breast cancer
. Participants commit to fundraising, training, and dedicating a three-day weekend to the event.
The net proceeds fund breast cancer research, education, and community outreach programs. Since its inception, more than $400 million has been raised.
will be the sole beneficiary.
Breast cancer
Breast cancer is cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating from ducts are known as ductal carcinomas; those originating from lobules are known as lobular carcinomas...
. Participants commit to fundraising, training, and dedicating a three-day weekend to the event.
About
Taking place in 15 cities in the USA, the 3-Day for the Cure is a series of three-day, 60-mile walk that raise millions of dollars for breast cancer research, education, and community health programs. Breast Cancer 3-Day participants raise a minimum of $2,300 and walk an average of 20 miles a day, educating thousands of people about breast health. Walkers must be at least 16 years old or be accompanied by an adult. Crew members must be at least 18 years old, and volunteers must be at least 10 years old. The Komen 3-Day for the Cure supports its participants before the event by providing coaches, training assistance, fundraising advice and a personal fundraising webpage.The net proceeds fund breast cancer research, education, and community outreach programs. Since its inception, more than $400 million has been raised.
Beneficiaries
In 2010, the Breast Cancer 3-Day will be renamed Susan G. Komen 3-Day for the Cure and Susan G. Komen for the CureSusan G. Komen for the Cure
Susan G. Komen for the Cure, formerly known as The Susan G. Komen Breast Cancer Foundation, often referred to as simply Komen, is the most widely known, largest and best-funded breast cancer organization in the US....
will be the sole beneficiary.